When DM patients were subdivided on the basis of their antidiabetic treatment, PFS in patients treated with metformin was twice as long as that of subjects on insulin (36 vs. 17 months), suggesting that metformin [56]. The gene discussed is INS; the disease is diabetes mellitus.